These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6640552)

  • 1. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T; Laszlo J; Moore J; Silverman P
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Taylor W; Laszlo J
    Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
    Sarna G; Figlin R; Callaghan M
    J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM; Weimar W; Marquet RL; Laméris JD; Jeekel J
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Laszlo J
    J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.
    Krown SE; Mintzer D; Cunningham-Rundles S; Niedzwiecki D; Krim M; Einzig AI; Gabrilove JL; Shurgot B; Gessula J
    Cancer Treat Rep; 1987 Jan; 71(1):39-45. PubMed ID: 3791267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
    Silver HK; Connors JM; Salinas FA
    Cancer Treat Rep; 1985; 69(7-8):743-50. PubMed ID: 4016785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal activity of recombinant clone a interferon in metastatic colon cancer.
    Neefe JR; Silgals R; Ayoob M; Schein PS
    J Biol Response Mod; 1984 Aug; 3(4):366-70. PubMed ID: 6481401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
    Sarna GP; Figlin RA
    Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL; Kenney P; Young D; Rinehart JJ
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract]   [Full Text] [Related]  

  • 19. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.